Sage Therapeutics Inc (NASDAQ: SAGE) Stock: Can It Change The Game?

In the last trading session, 0.88 million shares of the Sage Therapeutics Inc (NASDAQ:SAGE) were traded, and its beta was 0.91. Most recently the company’s share price was $10.90, and it changed around -$0.66 or -5.71% from the last close, which brings the market valuation of the company to $655.96M. SAGE currently trades at a discount to its 52-week high of $50.19, offering almost -360.46% off that amount. The share price’s 52-week low was $9.76, which indicates that the current value has risen by an impressive 10.46% since then. We note from Sage Therapeutics Inc’s average daily trading volume that its 3-month average coming to 1.27 million.

Sage Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.75. If we narrow it down even further, the data shows that 0 out of 15 analysts rate the stock as a Sell; another 6 rate it as Overweight. Among the rest, 1 recommended SAGE as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Sage Therapeutics Inc (NASDAQ:SAGE) trade information

Instantly SAGE has showed a red trend with a performance of -5.71% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -49.70% year-to-date, but still down -3.28% over the last five days. On the other hand, Sage Therapeutics Inc (NASDAQ:SAGE) is -3.71% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $47.65, which translates to bulls needing to increase their stock price by 77.12% from its current value. Analyst projections state that SAGE is forecast to be at a low of $15 and a high of $105.

Sage Therapeutics Inc (SAGE) estimates and forecasts

Sage Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -49.23 percent over the past six months and at a 28.40% annual growth rate that is well above the industry average of 13.20%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.28%. Sage Therapeutics Inc earnings are expected to increase by 28.08% in 2024, but the outlook is positive 16.80% per year for the next five years.